Skip to main content
Fig. 3 | Acta Neuropathologica Communications

Fig. 3

From: Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease

Fig. 3

Relative abundance of proteins with altered expression in CAA type-1 compared to Alzheimer’s disease cases and controls as determined by MS. Three groups of selected proteins (panels a-c), with altered levels (MS-derived, log2 LFQ intensity values) in CAA type-1 compared to the control groups and the AD groups. Selection criteria are specified in Fig. 2. Gene names are indicated

Back to article page